Mild Cognitive Impairment

There’s no doubt that we have entered an era when important opportunities will exist to delay or diminish the symptoms of dementia. As we’ve been covering in agebuzz, there is now a new drug (Leqembi) available to delay impairment and decline in patients with mild cognitive impairment or the early…

If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…

Remarkably, no matter how much we report on the benefits of walking for both physical and cognitive health, new research continues to be published that enhances and strengthens our understanding of the value of walking for healthier aging. Whether it’s reducing your mortality risk, maintaining your cardiovascular health, or lifting…

For the more than 6 million Americans currently thought to have Alzheimer’s, and their loved ones, the possible benefits of new medications can’t come soon enough. As the most common cause of dementia, Alzheimer’s Disease predominantly afflicts older women (⅔ of Alzheimer’s patients are female) and almost ¾ of those…

The Scottish novelist and playwright (and creator of Peter Pan) J. M. Barrie once said, “God gave us memories that we might have roses in December.” Memory, and the memories we store, allow us to live in a world more robust and rewarding than we might otherwise be able to…

According to the Alzheimer’s Association, more than 6 million Americans currently have Alzheimer’s Disease, with that number projected to rise to nearly 13 million by 2050. For people with Alzheimer’s or other types of cognitive impairment, and for those who care for them, the challenge is to stay active and…